Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07180147 · ClinicalTrials.gov registry record

Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

A clinical trial of Hypertension and Cardiovascular Disease, sponsored by Marymount University.

Active
Registry status
500
Enrollment target
1
Study location

NCT07180147: Active study of Hypertension and Cardiovascular Disease, sponsored by Marymount University.

NCT07180147 is a study of Hypertension and Cardiovascular Disease that is active but no longer recruiting, run by Marymount University. The registered enrollment target is 500 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07180147, a study of Hypertension and Cardiovascular Disease, is active but no longer recruiting, sponsored by Marymount University.

ACTIVE NOT RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The Arlington Longitudinal Optimal Healthy Aging (ALOHA) Study is a community-based research project led by the Marymount University Center for Optimal Aging (MCOA). The study is designed to help older adults in the Washington, D.C., Maryland, and Virginia (DMV) area maintain independence, mobility, wellbeing and brain health as they age. Adults aged 50 years and older will receive a comprehensive health assessment at the study site, Center for Optimal Aging- ALOHA Lab at Marymount University (MU) Ballston Campus in Arlington, Virginia. The assessment includes physical and cognitive testing, health and medical history, lifestyle surveys, and biometric measures such as blood pressure, grip strength, body composition by the InBody system, balance and gait speed. Participants will receive their results in a personalized "Health Passport," which summarizes findings and provides tailored recommendations to help manage modifiable health risk factors-such as those linked to Alzheimer's disease, cardiovascular disease, frailty syndrome, and depression. Participants will return annually for up to 5 years to repeat assessments and receive updated health and wellness recommendations. The study will track changes in health over time and explore the impact of the Health Passport on health behaviors, functional independence, and quality of life. ALOHA will also evaluate the cultural appropriateness of the Health Passport for diverse populations in Northern Virginia. The program incorporates an interprofessional research model, engaging researchers from multiple health professions to work alongside older adults, supporting both participants' wellness and optimal aging.

Primary Outcome

Health Passport Adherence Index (HPAI) Physical/Cardiovascular health; study-specific index. 5-item Likert index (0-4 per item), domain total 0-20; higher = better adherence. Unit: points.

Study Locations (1)

Virginia

  • Center for Optimal Aging, Marymount University - Arlington

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-05-01
Est. Completion 2031-07-30
Marymount University

6 total trials

What the registry record for NCT07180147 still lists

NCT07180147 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower).

The record links to 9 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT07180147 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT07180147 about?

NCT07180147 is a clinical study titled "Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)". The Arlington Longitudinal Optimal Healthy Aging (ALOHA) Study is a community-based research project led by the Marymount University Center for Optimal Aging (MCOA). The study is designed to help older adults in the Washington, D.C., Maryland, and Virginia (DMV) area maintain independence, mobility,...

What is the current status of trial NCT07180147?

This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2025-05-01. Estimated completion is 2031-07-30.

What conditions does trial NCT07180147 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Disease, Healthy Aging, Obesity & Overweight, Mild Cognitive Impairment (MCI).

Who is sponsoring clinical trial NCT07180147?

This trial is sponsored by Marymount University, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07180147 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07180147's enrollment target sits among peer trials

500 116th of 470 higher than 349 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07180147, the US trial registry maintained by the National Library of Medicine. NCT07180147 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.